Washington, D.C. – Today, U.S. Senators Susan Collins and Angus King announced that The Jackson Laboratory is receiving $480,536 from the National Institutes of Health (NIH). The grant will fund an innovative research project aimed at developing new treatments for Alzheimer's disease and related dementias (ADRDs).
"The work being done at The Jackson Laboratory is making tremendous strides in addressing the challenges posed by cognitive decline,” said Senators Collins and King. "This investment will better support efforts to contribute to breakthroughs in treatment for diseases like Alzheimer’s, offering hope for improved quality of life for the millions of American families affected by these conditions."
Specifically, researchers at The Jackson Laboratory are honing in on a vital pathway known as Angiopoietin/TIE2 (ANG/TIE2), which plays a crucial role in maintaining healthy vascular function. By delving into the intricate workings of the ANG/TIE2 pathway, the scientists aim to unlock novel strategies to protect brain vasculature from harm. This would have the potential to slow down or prevent cognitive decline in those afflicted with ADRDs.
Earlier this year, Senators Collins and King announced more than $1.2 million in funding secured for The Jackson Laboratory to support three separate biomedical research projects.
The Jackson Laboratory is an independent, nonprofit biomedical research institution headquartered in Bar Harbor. Its mission is to discover precise genomic solutions for diseases and empower the global biomedical community in the shared quest to improve human health.